Prerna Mewawalla, MD, discusses innovative strategies to enhance cancer care access, reduce clinician burden, and improve clinical trial diversity in real-world settings. As a hematologist and ...

No two clinical trials are the same, and therefore patient support can't be one-size-fits-all. Some patient populations—whether facing a rare disease, a difficult oncology diagnosis, or significant ...

The US Food and Drug Administration (FDA) is launching a pilot to implement real-time clinical trials (RTCT). While announcing the pilot, the FDA revealed that two proof-of-concept clinical trials ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

The Food and Drug Administration on Tuesday kicked off an effort to use AI and other data science tools to monitor clinical trials in real time and cut down review times for new drugs. Why it matters: ...

Earlier this year, the FDA announced a breakthrough that could fundamentally transform how medical evidence reaches patients. For the first time in the agency’s history, regulators will monitor ...

The latest episode of The Top Line, sponsored by ViiV Healthcare, features Dr. Luis Buzón, an infectious disease specialist, discussing the critical role of real-world evidence in HIV treatment and ...

A new study by researchers at the Icahn School of Medicine at Mount Sinai, Memorial Sloan Kettering Cancer Center, and collaborators, suggests that artificial intelligence (AI) could significantly ...

The U.S. FDA announced on Tuesday that Amgen (AMGN) and AstraZeneca (AZN) have initiated real-time clinical trials as the agency seeks to launch a pilot program designed to accelerate drug development ...

Creators of drug-approval trials strive for clinical homogeneity when choosing inclusion criteria for the patient-participants. The too old, the too sick generally remain outside the chosen parameters ...